Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity

Publikace na 1. lékařská fakulta |

2005

anti-cancer chemotherapy, doxorubicin, anti-tumor immunity, HPMA copolymer conjugates